BioLife Solutions BLFS Cumulative Cost Basis
Cumulative Cost Basis at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.
The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioLife Solutions's cumulative cost basis.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is BioLife Solutions's cumulative cost basis?
- BioLife Solutions (BLFS) reported cumulative cost basis of $88.79M in Q1 2026.
- How has BioLife Solutions's cumulative cost basis changed year-over-year?
- BioLife Solutions's cumulative cost basis increased by 118.4% year-over-year, from $40.66M to $88.79M.
- What is the long-term trend for BioLife Solutions's cumulative cost basis?
- Over 3 years (2022 to 2025), BioLife Solutions's cumulative cost basis has grown at a 24.9% compound annual growth rate (CAGR), from $44.64M to $87.01M.